BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22414731)

  • 1. Paclitaxel-loaded ethosomes®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses.
    Paolino D; Celia C; Trapasso E; Cilurzo F; Fresta M
    Eur J Pharm Biopharm; 2012 May; 81(1):102-12. PubMed ID: 22414731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for actinic keratosis.
    Ulrich M; Drecoll U; Stockfleth E
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):545-55. PubMed ID: 20670178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
    Erlendsson AM
    Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinic keratosis: facts and controversies.
    Ko CJ
    Clin Dermatol; 2010; 28(3):249-53. PubMed ID: 20541675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative agents for actinic keratosis and nanocarriers enhancing skin penetration.
    Schäfer-Korting M; Höltje M; Korting HC; Höltje HD
    Skin Pharmacol Physiol; 2010; 23(1):6-14. PubMed ID: 20090403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin.
    Hodges A; Smoller BR
    Mod Pathol; 2002 Nov; 15(11):1121-5. PubMed ID: 12429789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical AC-11 abates actinic keratoses and early squamous cell cancers in hairless mice exposed to Ultraviolet A (UVA) radiation.
    Mentor JM; Etemadi A; Patta AM; Scheinfeld N
    Dermatol Online J; 2015 Apr; 21(4):. PubMed ID: 25933088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes.
    Anwar J; Wrone DA; Kimyai-Asadi A; Alam M
    Clin Dermatol; 2004; 22(3):189-96. PubMed ID: 15262304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts.
    Xie M; Zhou L; Hu T; Yao M
    Anticancer Drugs; 2007 Apr; 18(4):459-66. PubMed ID: 17351398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5% fluorouracil chemowraps in the management of widespread lower leg solar keratoses and squamous cell carcinoma.
    Tallon B; Turnbull N
    Australas J Dermatol; 2013 Nov; 54(4):313-6. PubMed ID: 23651243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation.
    Berman B; Cockerell CJ
    J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S10-9. PubMed ID: 23228301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology and pathobiology of actinic (solar) keratosis - an update.
    Roewert-Huber J; Stockfleth E; Kerl H
    Br J Dermatol; 2007 Dec; 157 Suppl 2():18-20. PubMed ID: 18067626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
    Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
    Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells.
    Wang C; Ho PC; Lim LY
    Int J Pharm; 2010 Nov; 400(1-2):201-10. PubMed ID: 20804835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspects.
    Oppel T; Korting HC
    Skin Pharmacol Physiol; 2004; 17(2):67-76. PubMed ID: 14976383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
    Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
    Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemowraps as an adjuvant to surgery for patients with diffuse squamous cell carcinoma of the extremities.
    Mann M; Berk DR; Petersen J
    J Drugs Dermatol; 2008 Jul; 7(7):685-8. PubMed ID: 18664163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Actinic keratoses].
    Babilas P; Landthaler M; Szeimies RM
    Hautarzt; 2003 Jun; 54(6):551-60; quiz 561-2. PubMed ID: 12858853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized delivery of cisplatin for the effective management of squamous cell carcinoma from protransfersome formulation.
    Gupta V; Karthikeyan C; Trivedi P
    Arch Pharm Res; 2012 May; 35(5):851-9. PubMed ID: 22644852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of the histopathologic examination in the diagnosis and management of the actinic keratosis.
    Vîlcea AM; Vîlcea ID; Georgescu CV; Pătraşcu V
    Rom J Morphol Embryol; 2012; 53(4):927-34. PubMed ID: 23303015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.